AorTech shares up on latest US patent approval
27th May 2020 16:05
(Sharecast News) - Medical device company AorTech International announced on Wednesday that the United States Patent and Trademark Office has said that its application 15/995,050 would issue as US patent 10,676,560, entitled 'biostable polyurethanes', on 9 June.
Read moreAorTech's annual royalty revenues grow, sees 'positive' R&D progress
13th May 2020 08:17
(Sharecast News) - Medical polymers manufacturer AorTech said royalty revenues continued to grow in its last trading year and highlighted that progress in research and development projects had all been "positive".
Read moreAorTech to buy manufacturing partner RUA Medical Devices
11th Mar 2020 14:52
(Sharecast News) - Biostable polymer and medical devices company AorTech International has entered into a conditional agreement with non-executive director David Richmond to acquire RUA Medical Devices, an Ayrshire-based innovative and experienced implantable fabric specialist and full service contract medical device developer and manufacturer, ti announced on Wednesday.
Read moreAorTech to test 'novel method' for heart valve manufacture
6th Jan 2020 10:21
(Sharecast News) - AorTech International, the licensor of long-term implantable biostable polymer 'Elast-Eon' and a developer of medical devices using the key properties of Elast-Eon, updated the market on its progress with the manufacture process design for its polymeric heart valve.
Read moreAorTech International loss widens as R&D investment rises
29th Nov 2019 08:00
(Sharecast News) - AorTech International on Friday reported a slightly widened loss as it transformed into a medical device company.
Read moreAorTech shares surge on agreement with Medibrane
27th Nov 2019 16:27
(Sharecast News) - Medical devices company AorTech International has entered into an intellectual property licence agreement with Medibrane, it announced on Wednesday, allowing the use of its 'Elast-Eon' product for the encapsulation of medical devices.
Read moreAorTech continues to shift focus towards life-changing medical devices
11th Oct 2019 09:38
(Sharecast News) - AorTech told investors on Friday that it had spent much effort in laying the foundations for its transition into a developer of life-changing medical devices during the six months ended 30 September.
Read moreAorTech revenues grow as group adopts new strategy
14th May 2019 11:20
(Sharecast News) - Polymers developer AorTech saw revenues increase in a trading year that saw it adopt a new strategy, successfully conclude a fundraising and strengthen its board.
Read moreAortech's loss widens amid transformation to medical device developer
22nd Nov 2018 12:19
(Sharecast News) - Aortech International reported that its loss widened as the company transitions into the medical device development market.
Read moreAorTech confident in future following fundraising
23rd Aug 2018 14:02
(Sharecast News) - Investors in medical device development company AorTech International were told of how the firm was in the process of transitioning from a company focussed on licensing to a medical device development business following its recent fundraising on Thursday, as they gathered for the annual general meeting.
Read moreAorTech's full year operating losses widen on bad debt provisions
15th Aug 2016 15:18
(ShareCast News) - AorTech International on Monday reported an increase in full year operating losses, reflecting bad debt provisions. The biomaterials and medical device IP company said operating losses rose to $575,000 in the year ended 31 March 2016 from $455,000 the previous year. The company i
Read moreAorTech International posts decline in interim revenue
27th Nov 2015 12:54
(ShareCast News) - Intellectual property group AorTech International said its performance in the first half of the year was in line with forecasts, despite a decline in revenue. In the six months to 30 September, revenue fell 27.5% year-on-year to $380,000 (£252,000), while the company's operating l
Read moreAortech International spikes as losses slashed
7th Aug 2015 10:13
(ShareCast News) - Shares in AIM-listed medical device group Aortech International surged above 12-month highs as annual losses were more than halved and the company gave bullish indications on cash positivity. Revenue from continuing operations and other income of $0.84m was slightly more than doub
Read moreAorTech dives on higher costs
16th Jun 2014 13:52
Shares in medical device maker AorTech dived after the group revealed the costs associated with one of its most recent licensees, Biomerics. The firm is responsible for the manufacture and supply of AorTech's polymers to all of its customers and potential customers. Biomerics's validation process
Read moreJohn Laing Chairman subscribes for shares in firm's largest ever raising
9th Oct 2013 16:20
John Laing Infrastructure Fund (JLIF) announced that two of its directors, Chairman Paul Lester and fellow board member Chris Spencer, had each subscribed for 20,000 newly issued shares in the group as part of its largest ever raising of new equity. The shares were priced at 111p, costing each of
Read more